Published Date: 08 Mar 2023
Results from the RESCUE BT2 trial showed that among patients with mild or major strokes, more patients taking tirofiban had better 90-day outcomes than aspirin.
Read Full NewsMRI offers the possibility of personalized neoadjuvant chemotherapy for patients with HER2-positive breast cancer, but it may not be ready for prime time.
Patients with non-squamous non-small cell cancer may achieve similar outcomes with a subcutaneous formulation of the immunotherapy toripalimab as with IV administration.
Conditional approval of intravesical gene therapy was supported by clinical evidence showing a 53.4% complete response rate in patients with treatment-resistant non-muscle-invasive bladder cancer.
A phase 2 study evaluates the safety and efficacy of brexucabtagene autoleucel in BTKi-naïve patients with relapsed/refractory mantle cell lymphoma.
1.
Canadian Group Calls for Earlier Colorectal Cancer Screening
2.
Through the activation of bitter taste receptors, lidocaine has the potential to kill some cancer cells.
3.
'Significant Milestone' for Radionuclide Therapy in Refractory Meningioma
4.
Cancer tumor anatomy influences the benefits of chemotherapy for patients with early-stage breast cancer.
5.
Research exposes far-reaching toll of financial hardship on patients with cancer
1.
Unlocking the Potential of Cancer Antigen 19-9 for Early Detection
2.
ADCs and Bispecific Antibodies: Advancing the Future of Cancer Immunotherapy
3.
Introduction To Immune Thrombocytopenic Purpura
4.
Integrating Immunotherapy and Staging Guidelines in Lung Cancer Treatment
5.
Beyond the Biopsy: The Evolving Landscape of Prostate Cancer Management
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part III
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
5.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation